Test Price
2,800 AEDโ Home Collection Available
COL3A1 Gene Ehlers-Danlos Syndrome Type 3 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM โ 11 PM daily).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The COL3A1 gene test utilizes advanced Next-Generation Sequencing (NGS) to identify pathogenic mutations associated with vascular Ehlers-Danlos syndrome (vEDS). This test enables definitive diagnosis, targeted surveillance, and family risk assessment through full gene sequencing and copy number variant (CNV) detection.
| Feature | Our Test (COL3A1 NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Method Precision | Full gene sequencing + CNV detection | Targeted exon sequencing only |
| Analytical Sensitivity | >99% for SNVs/indels, CNVs included | ~95% for selected exons |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks |
Physician Insight & Safety Protocols
"This test uncovers silent vascular risk. A negative result does not exclude all EDS subtypes; clinical correlation with skin and vascular imaging remains essential. I encourage you to discuss every outcome with your physician to build a personalised care plan."
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
โ Important Clinical Advisory
Do not discontinue any prescribed medication without first consulting your treating doctor. Genetic results may influence long-term management, not acute therapy. A mandatory genetic counseling session is required prior to sample collection.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Active bleeding disorder, inability to provide informed consent, acute severe cardiovascular event within last 30 days.
- Absolute Contraindication for Blood Draw: Cellulitis or infection at phlebotomy site.
- Emergency Red Flags โ seek immediate care if: sudden tearing chest or abdominal pain, unexplained collapse, new severe bruising or arterial rupture symptoms.
All genetic testing follows UAE Federal Decree-Law No. 4 of 2016 on Medical Liability and informed consent protocols.
Patient FAQ & Clinical Guidance
1. What is the purpose of the COL3A1 gene test for Ehlers-Danlos syndrome type 3?
This identifies mutations in COL3A1 that cause vascular Ehlers-Danlos syndrome, enabling early detection of life-threatening arterial fragility. Early diagnosis allows for proactive surveillance and family screening.
2. How is the sample collected and are there special preparations?
A small blood sample is drawn via VIP mobile phlebotomy at your home; no fasting or medication adjustments are required. Genetic counseling is mandatory before testing to ensure informed consent.
3. What actions should I take if the result is positive?
A positive result requires immediate consultation with a vascular specialist and genetic counsellor to establish a surveillance plan and consider family screening. Regular monitoring including echocardiography and vascular imaging is recommended.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance Framework
All genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genomic information is encrypted, access-restricted, and never shared without explicit written consent.
Clinical & Logistical Metadata
| Test Name | COL3A1 Gene Ehlers-Danlos Syndrome Type 3 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (3โ5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV analysis |
| ICD-10-CM Code | Q79.6 |
| LOINC Code | 21636-6 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians